Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RVL PHARMACEUTICALS PLC

(RVLP)
  Rapport
Geschatte realtime Cboe BZX  -  18:29 07-10-2022
2.305 USD   +2.44%
30/08RVL Pharmaceuticals gaat een marketingpartnerschap aan met Revision Skincare
MT
30/08Revision Skincare® kondigt strategisch partnerschap aan met RVL Pharmaceuticals plc
CI
22/08RVL dient registratieverklaring in namens verkopende aandeelhouders
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Nieuws in andere talen op RVL PHARMACEUTICALS PLC
12/09Rvl Pharmaceuticals : View Presentation
30/08RVL Pharmaceuticals plc to Present at the H.C. Wainwright 24th Annual Global Investment..
30/08RVL Pharmaceuticals to Form Marketing Partnership With Revision Skincare
30/08Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals plc
30/08Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals plc
22/08RVL Files Registration Statement on Behalf of Selling Shareholders
11/08RVL PHARMACEUTICALS PLC Management's Discussion and Analysis of Financial Condition an..
11/08Transcript : RVL Pharmaceuticals plc, Q2 2022 Earnings Call, Aug 11, 2022
11/08Rvl Pharmaceuticals : Reports Second Quarter 2022 Financial Results; Provides Commercial U..
11/08Rvl Pharmaceuticals Plc : Results of Operations and Financial Condition, Change in Directo..
11/08Earnings Flash (RVLP) RVL PHARMACEUTICALS Reports Q2 Revenue $8.4M, vs. Street Est of $..
11/08Earnings Flash (RVLP) RVL PHARMACEUTICALS Posts Q2 Loss $-0.14, vs. Street Est of $-0.2..
11/08RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commerc..
11/08RVL Pharmaceuticals plc Reports Earnings Results for the Second Quarter and Six Months ..
08/08RVL Pharmaceuticals plc announced that it has received $23.949999 million in funding fr..
05/08Rvl Pharmaceuticals : Material Definitive Agreement - Form 8-K
04/08Rvl Pharmaceuticals Plc : Entry into a Material Definitive Agreement, Creation of a Direct..
04/08RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing
04/08RVL Pharmaceuticals plc to Discuss Second Quarter 2022 Financial Results and Provide Co..
04/08RVL Pharmaceuticals plc announced that it expects to receive $23.949999 million in fund..
07/07Rvl Pharmaceuticals : Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales ..
07/07RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product S..
07/07RVL Pharmaceuticals plc Reaffirms Sales Guidance for the Fourth Quarter of 2022
24/06RVL Pharmaceuticals plc(NasdaqGS:RVLP) added to Russell..
24/06RVL Pharmaceuticals plc(NasdaqGS:RVLP) added to Russell..
17/06Rvl Pharmaceuticals Plc : Submission of Matters to a Vote of Security Holders (form 8-K)
16/06RVL Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting
16/05RVL Pharmaceuticals plc to Present at Upcoming Conferences
12/05RVL PHARMACEUTICALS PLC Management's Discussion and Analysis of Financial Condition an..
12/05Transcript : RVL Pharmaceuticals plc, Q1 2022 Earnings Call, May 12, 2022
12/05Earnings Flash (RVLP) RVL PHARMACEUTICALS Posts Q1 Revenue $21.4M
12/05RVL Pharmaceuticals plc Reports First Quarter 2022 Financial Results; Provides Commerci..
12/05RVL Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, ..
12/05RVL Pharmaceuticals plc Reaffirms Sales Guidance for the Fourth Quarter of 2022
09/05UPNEEQ® Wins Best Professional-Treatment Product by Shape Magazine in the 2022 "Shape H..
05/05RVL Pharmaceuticals plc to Discuss First Quarter 2022 Financial Results and Provide Com..
11/04Rvl Pharmaceuticals Plc : Change in Directors or Principal Officers (form 8-K)
11/04Andrew Einhorn Resigns as Chief Financial Officer of RVL Pharmaceuticals, Effective Apr..
06/04Rvl Pharmaceuticals : Announces Preliminary First Quarter 2022 UPNEEQ® Net Product Sales R..
06/04RVL Pharmaceuticals plc Announces Preliminary Sales Results for the First Quarter of 20..
06/04RVL Pharmaceuticals plc Reaffirms Net Sales Guidance for the Fourth Quarter of 2022
06/04UPNEEQ® Wins "Best in Innovation" Award from New Beauty
06/04RVL Pharmaceuticals plc Announces Preliminary First Quarter 2022 UPNEEQ® Net Product Sa..
04/04Rvl Pharmaceuticals Plc : Entry into a Material Definitive Agreement, Financial Statements..
04/04RVL Pharmaceuticals, Inc. Entered into the First Amendment to License Agreement with Sa..
30/03Rvl Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results; Provide..
30/03RVL PHARMACEUTICALS PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
30/03RVL Pharmaceuticals Q4 Loss Narrows Amid Rising revenue, Issues Guidance -- Stock Up 4%..
30/03RVL Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2..
30/03Transcript : RVL Pharmaceuticals plc, Q4 2021 Earnings Call, Mar 30, 2022
30/03Earnings Flash (RVLP) RVL PHARMACEUTICALS Reports Q4 Revenue $1.1M, vs. Street Est of $..
30/03RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Pr..
30/03RVL Pharmaceuticals plc Announces Impairment Charges for the Quarter Ended December 31,..
30/03RVL Pharmaceuticals plc Auditor Raises 'Going Concern' Doubt
23/03RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2021 Financial Results ..
16/03Transcript : RVL Pharmaceuticals plc Presents at Barclays Global Healthcare C..
09/03RVL Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2022
19/01UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Phar..
19/01Transcript : Osmotica Pharmaceuticals plc - Special Call
19/01Osmotica Pharmaceuticals Changes Name, Provides Q4'22 Net Sales Guidance
19/01Osmotica Pharmaceuticals : Announces Corporate Name Change to RVL Pharmaceuticals plc, New..
19/01Rvl Pharmaceuticals Plc : Results of Operations and Financial Condition (form 8-K)
19/01Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc..
19/01RVL Pharmaceuticals plc Provides Net Sales Guidance for the Fourth Quarter of 2022
19/01RVL Pharmaceuticals plc(NasdaqGS:RVLP) added to NASDAQ ..
18/01Osmotica Pharmaceuticals : Amendments to Articles of Incorporation/Bylaws/Change in Fiscal..
18/01Osmotica Pharmaceuticals Plc : Amendments to Articles of Inc. or Bylaws; Change in Fiscal ..
18/01RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19,..
18/01RVL Pharmaceuticals plc(NasdaqGS:OSMT) dropped from NAS..
17/01Osmotica Pharmaceuticals plc has Changed its Name to RVL Pharmaceuticals plc
06/01Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on Janua..
2021Insider Buy: Osmotica Pharmaceuticals
2021Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
2021Osmotica Pharmaceuticals plc(NasdaqGS:OSMT) dropped..
2021Osmotica Pharmaceuticals : Corporate Presentation December 2021
2021Osmotica Pharmaceuticals Plc : Regulation FD Disclosure (form 8-K)
2021Osmotica Pharmaceuticals : Reports Third Quarter 2021 Results and Provides Business Update..
2021OSMOTICA PHARMACEUTICALS PLC Management's Discussion and Analysis of Financial Conditi..
2021Osmotica Pharmaceuticals plc Reports Earnings Results for the Third Quarter and Nine Mo..
2021Transcript : Osmotica Pharmaceuticals plc, Q3 2021 Earnings Call, Nov 15, 202..
2021Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business U..
2021Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conferen..
2021Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Updat..
2021Osmotica Pharmaceuticals Plc : Change in Directors or Principal Officers, Financial Statem..
2021Osmotica Pharmaceuticals plc Announces the Retirement of Fred Weiss as Director
2021Osmotica Pharmaceuticals : Closes Shares, Warrants Offering for..
2021Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offer..
2021Osmotica Pharmaceuticals : plc Announces Closing of $35 Million Underwritten Public Offeri..
2021Osmotica Pharmaceuticals : PART II INFORMATION NOT REQUIRED IN PROSPECTUS - Form 8-K
2021Osmotica Pharmaceuticals Plc : Creation of a Direct Financial Obligation or an Obligation ..
2021After Hours Watch List Scorecard: CYRN, RKLB, OSMT
2021Health Care Stocks Ending Near Top of Thursday Leaderboard
2021Health Care Stocks Posting Gains in Thursday Trading
2021Osmotica Pharmaceuticals : Pharma Enters Up to $100 Million Deb..
2021Wall Street Set for Higher Open as Debt Ceiling Worries Subside
2021Health Care Stocks Gain Premarket Thursday
2021Osmotica Pharmaceuticals : Announces Debt Financing from Athyrium Capital Management of up..
2021Osmotica Pharmaceuticals : Prices Offering of Shares, Warrants ..
2021Osmotica Pharmaceuticals : Prices Offering of Shares, Warrants
2021Osmotica Pharmaceuticals : Announces Pricing of $35 Million Underwritten Public Offering
Volgende evenement op RVL PHARMACEUTICALS PLC